Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer (SORAMIC)
This study is currently recruiting participants.
Verified March 2013 by University of Magdeburg
Sponsor:
University of Magdeburg
Collaborators:
Bayer Pharma AG
Sirtex Medical
Information provided by (Responsible Party):
Jens Ricke, University of Magdeburg
ClinicalTrials.gov Identifier:
NCT01126645
First received: May 17, 2010
Last updated: March 1, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2014 |
| Estimated Primary Completion Date: | September 2014 (Final data collection date for primary outcome measure) |